3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroendocrine Tumors
5
Carcinoma, Hepatocellular
5
Stomach Neoplasms
4
Esophageal Neoplasms
4
Weight Loss
3
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Breast Neoplasms
3
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Malnutrition
2
Intestinal Obstruction
2
Duodenal Neoplasms
2
Diarrhea
2
Colorectal Neoplasms
2
Carcinoid Tumor
2
Adenoma, Islet Cell
2
Acromegaly
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vomiting
1
Vipoma
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Somatostatinoma
1
Serotonin Syndrome
1
Sarcoma
1
Rectal Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
12
gallium Ga 68 dotatate
6
Everolimus
6
lutetium Lu 177 dotatate
5
Radiosurgery
5
Proton Therapy
5
Bevacizumab
5
pembrolizumab
4
Surveys and Questionnaires
4
Specimen Handling
4
Hydroxyurea
4
abemaciclib
3
Tranexamic Acid
3
Surgical Procedures, Operative
3
Sodium Chloride
3
Ga(III)-DOTATOC
3
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
3
vistusertib
2
trametinib
2
ribociclib
2
arginyllysine
2
aldesleukin
2
Yoga
2
Whole Body Imaging
2
Sunitinib
2
Saline Solution
2
Ropivacaine
2
Radiotherapy
2
Protons
2
Observation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Meningioma
×
Octreotide
×
Clear all
NCT02333565
2023-05-25
CEVOREM
Assistance Publique Hopitaux De Marseille
Phase 2
Completed
20 enrolled